epithalon tablets Epithalon AEDG Research Peptide –

Assessment Phase The first 7 to 14 days of a cycle serve as an assessment period

Long-term use reduces spontaneous tumor development in some models

Can Dragon Pharma BPC 157 be stacked with TB 500

Primary peptides: KPV at 300 to 500 mcg subcutaneously daily (mast cell stabilization) BPC-157 at 250 mcg subcutaneously twice daily (tissue repair, additional mast cell stabilization) Support peptide: Ta1 at 1.6 mg subcutaneously twice weekly (immune regulation) Implementation schedule: Week 1: Start KPV alone at lower dose (200 mcg) to assess tolerance Week 2: Add BPC-157 at 200 mcg twice daily

compounding pharmacies and have not been reviewed by the FDA for safety, effectiveness, or quality

DOI: 10.1016/j.cell.2017.02.031